FHD-286

· Foghorn Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for FHD-286, covering 2024-04-25 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia [Phase 1]